P. Doty et al., EFFECTS OF ONDANSETRON PRETREATMENT ON ACUTE RESPONSES TO ETHANOL IN SOCIAL DRINKERS, Behavioural pharmacology, 5(4-5), 1994, pp. 461-469
Laboratory animal and clinical studies suggest that the 5-HT3 receptor
subtype may mediate some of the CNS effects of ethanol. Two experimen
ts were conducted to evaluate the effects of the 5-HT3 receptor antago
nist, ondansetron, on the acute responses of social drinkers to a mode
rate dose of ethanol. In Experiment 1, two doses of ondansetron (0.15
and 0.30 mg) or placebo were tested in combination with ethanol (0.5)
g/kg or placebo. In Experiment 2, three higher doses of ondansetron (1
.0, 3.0 and 10.0 mg) or placebo were tested in combination with ethano
l (0.5 g/kg) or placebo. Sessions were conducted one or two evenings p
er week from 16.00 h until 20.45 h. Separate groups of subjects partic
ipated in the two placebo-controlled, double-blind experiments (Experi
ment 1: n = 13; Experiment 2: n = 6). The order of drug administration
was counterbalanced across subjects. In each study, subjects were giv
en an intravenous infusion of ondansetron and 5 min later consumed an
ethanol or placebo beverage. For 3 h after the beverage was consumed,
physiological, subjective effects and performance measures were taken
at regular intervals. Across a wide range of doses, the effects of ond
ansetron alone did not differ significantly from placebo. Ethanol alon
e produced prototypic effects on several measures (e.g., increased rat
ings of ''positive'' subjective effects and impaired memory performanc
e). Furthermore, ondansetron pretreatment did not modify physiological
, subjective or performance effects of ethanol. These findings do not
support the hypothesis that the 5-HT3 receptor/channel complex mediate
s the positive subjective effects, or any other subjective or performa
nce effects, of ethanol.